Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vericiguat Dose Finding in HFpEF (SOCRATES-PRESERVED)
NCT01951638Phase 2Completed
- Sponsor
- Bayer
- Start
- Nov 2013
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 25
01
Overview
A Phase 2 trial of vericiguat in heart failure with preserved ejection fraction (HFpEF), sponsored by Bayer. Started Nov 2013; status: completed.
02
Drugs
vericiguat
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT01951638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01951638.